Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

Feeling bloated? Got a headache? Need a mental boost?

Feeling bloated? Got a headache? Need a mental boost?

Peppermint's got your back! From soothing tummy troubles to zapping headaches, this little oil does it all!

Are you ready to add some peppermint magic in your life?

Suggested For You

🎉 Go Tigrox!! 🐅

🎉 Go Tigrox!! 🐅

Thanks to YOUR incredible support, TIGROX Tiger Milk King has roared its way into the Malaysia Book of Records! 📚🏆 We couldn’t have done it without you!

And that’s not all – our success story is making headlines in the popular local newspaper Nanyang Siang Pao! 📰 Thank you so much, we couldn't be anymore prouder!

From the bottom of our hearts, THANK YOU for being a vital part of our journey and for your unwavering support.

Together, we're making a roaring, positive impact! 🌟🙌

Feeling STRESSED? 😣😣

Feeling STRESSED? 😣😣

It's OKAY! Stress is part of modern living. The key is learning how to co-exist harmoniously with stress.

Here are some quirky and unique ways to help you deal with stress to live a happier and more productive life! 😜😛

Game on! 🦑

Game on! 🦑

Say goodbye to creaky knees and hello to smooth, sweet victories!

With MoveOn and LiveOn, you’re always on top of the game - no matter what life serves you.

🎉让我们用我们首席执行官的励志话语来启动2024吧!🌟 第一季度的热门和推荐产品就是我们的 ZENSO 体重管理系列。你可以通过专家建议,掌握节后不反弹的诀窍。你还可以参考我们的 3 个月的减重挑战,一起揭秘恢复体型的秘密,让2024 成为你最健康的一年!💪

🎉让我们用我们首席执行官的励志话语来启动2024吧!🌟 第一季度的热门和推荐产品就是我们的 ZENSO 体重管理系列。你可以通过专家建议,掌握节后不反弹的诀窍。你还可以参考我们的 3 个月的减重挑战,一起揭秘恢复体型的秘密,让2024 成为你最健康的一年!💪


点击下方链接,浏览完整时事简报,启动更健康、更快乐的旅程!💫💚

https://cdn.wellous.com/membership/article/newsletter/2024/2024-q1-cn.pdf

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

你知道吗?🤔 将近 40% 马来西亚成年人患有非酒精性脂肪肝(NAFLD),这也是马来西亚最常见的肝脏疾病。

我们最新一期的时事简报将带你深入探讨肝脏健康!本期的资讯内容涵盖了一系列常见的肝脏疾病,探索了预防病毒性肝炎和脂肪肝的方法,以及我们本期的重点产品 - LIVETAL 和 HOMEGA,为你的肝脏健康助力加持!还有,也别错过了试试我们这期的数字排毒挑战,让自己暂时“退出”数字世界,全面地身心放松!🧡✨

点击下方链接查看完整的时事简报,了解更多关于保持肝脏健康的知识吧!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-cn.pdf